Tempus AI
PaidPrecision medicine platform using AI and genomics to power cancer diagnostics, clinical trial matching, and multimodal data insights for oncology and beyond.
What is Tempus AI?
Tempus AI (NASDAQ: TEM) is a Chicago-based health technology company founded in 2015 by Eric Lefkofsky that has built the world's largest multimodal clinical and molecular data library, spanning over 40 million patient records. Its precision medicine platform combines genomic testing (xT DNA, xF liquid biopsy, xR RNA), AI-powered diagnostics, and a data applications layer to help oncologists, cardiologists, and researchers make more informed treatment decisions. Tempus generated $1.27 billion in revenue in 2025, driven by its oncology testing business, the February 2025 acquisition of Ambry Genetics for hereditary risk testing, and its Lens data platform used by 90% of top biopharma companies for drug discovery. Its Tempus One AI clinical copilot surfaces actionable genomic insights directly in the EHR, while Tempus Next identifies care gaps across patient populations.
Key Features
Integrations
How to Use Tempus AI
✅ Best For
- Oncologists, precision medicine teams, and research coordinators at academic medical centers and large cancer programs who need comprehensive genomic profiling to guide treatment decisions. Biopharma companies and research organizations looking to license de-identified multimodal clinical data or access Tempus's Lens platform for biomarker discovery and clinical trial optimization.
❌ Not For
- General practitioners or small practices without oncology focus who do not regularly order genomic testing. Organizations seeking ambient documentation, clinical note generation, or administrative AI tools rather than diagnostics and research data platforms.
Reviews
No reviews yet. Be the first to review Tempus AI!
Pricing
- ✓Oncology
- ✓hereditary
- ✓pharmacogenomic
- ✓and MRD panels
- ✓Multi-year Lens platform contracts for biopharma and research
- ✓Integrated health system and clinical copilot deployment
Prompts to Try
What targeted therapies are indicated based on this patient's xT genomic report?
Identify patients in our system who may benefit from MRD monitoring
Which clinical trials match this patient's biomarker profile?
Use Cases
Alternatives to Tempus AI
Generative AI clinical documentation platform that transforms conversations into structured notes, pre-visit summaries, and revenue cycle outputs.
Visit Website →AI-powered symptom checker that helps users understand symptoms and navigate to appropriate care using clinical reasoning.
Visit Website →Free AI-powered symptom checker and care navigation platform built by Harvard doctors to guide users to the right care and reduce unnecessary ER visits.
Visit Website →Google's suite of AI health research tools including MedGemma, AMIE, and Med-Gemini for developers, clinicians, and researchers advancing precision medicine.
Visit Website →Epic's built-in AI suite including Art (clinician scribe), Emmie (patient assistant in MyChart), and Penny (revenue cycle automation), used by 85% of Epic customers.
Visit Website →API-first AI medical guidance platform for digital triage, symptom assessment, and patient intake with a certified probabilistic clinical reasoning engine.
Visit Website →Ambient AI assistant for clinicians that converts patient conversations into structured notes, coding suggestions, and EHR-ready documentation.
Visit Website →Free AI-powered medical search engine for verified clinicians delivering cited, evidence-based answers from peer-reviewed literature in seconds.
Visit Website →AI-powered digital pathology platform that automates slide analysis, biomarker quantification, and drug development support for labs and biopharma.
Visit Website →Ambient Clinical Intelligence platform that automates documentation, coding, and clinical reasoning for clinicians across 100+ specialties.
Visit Website →